Información del miembro
Pr Luca Rossetti
Italia
Equipo
Dr Leonardo Colombo
Italia
Centro HCP
contacto
ASST Santi Paolo e Carlo, Milan, Italy
Los ensayos clínicos
An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2-.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy ofrhNGF in Patients With Retinitis Pigmentosa (RP)
Global Patient Registry of Inherited Retinal Disease
Global Patient Registry of Inherited Retinal Disease
A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene